Wilson S P
Department of Pharmacology, University of South Carolina School of Medicine, Columbia 29208.
Life Sci. 1991;49(4):269-72. doi: 10.1016/0024-3205(91)90013-2.
Insulin-like growth factor I (IGF-I) increased both the contents of proenkephalin-derived enkephalin-containing peptides and the activity of dopamine beta-hydroxylase in bovine adrenal chromaffin cells. These increases in dopamine beta-hydroxylase and enkephalin-containing peptides continued for at least 8 days. The half-maximal IGF-I concentration for these effects was approximately 1 nM, with maximal effects observed at 10-30 nM. In contrast, insulin was 1000-fold less potent. Pretreatment of chromaffin cells with IGF-I increased the rate of [35S]proenkephalin synthesis 4-fold compared to untreated cells. Total protein synthesis increased only 1.5-fold under these conditions. These results suggest that IGF-I may be a normal regulator of chromaffin cell function.
胰岛素样生长因子I(IGF-I)可增加牛肾上腺嗜铬细胞中源自前脑啡肽的含脑啡肽肽的含量以及多巴胺β-羟化酶的活性。多巴胺β-羟化酶和含脑啡肽肽的这些增加持续至少8天。这些作用的IGF-I半数最大浓度约为1 nM,在10 - 30 nM时观察到最大作用。相比之下,胰岛素的效力要低1000倍。与未处理的细胞相比,用IGF-I预处理嗜铬细胞可使[35S]前脑啡肽的合成速率提高4倍。在这些条件下,总蛋白质合成仅增加1.5倍。这些结果表明IGF-I可能是嗜铬细胞功能的正常调节因子。